Early hybrid cardiac rehabilitation in congenital heart disease: the QUALIREHAB trial.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Amedro Pascal, Gavotto Arthur, Huguet Helena, Souilla Luc, Huby Anne-Cecile, Matecki Stefan, Cadene Anne, De La Villeon Gregoire, Vincenti Marie, Werner Oscar, Bredy Charlene, Lavastre Kathleen, Abassi Hamouda, Cohen Sarah, Hascoet Sebastien, Dauphin Claire, Chalard Aurelie, Dulac Yves, Souletie Nathalie, Bouvaist Helene, Douchin Stephanie, Lachaud Matthias, Ovaert Caroline, Soulatges Camille, Combes Nicolas, Thambo Jean-Benoit, Iriart Xavier, Bajolle Fanny, Bonnet Damien, Ansquer Helene, Delpey Jean-Guillaume, Cohen Laurence, Picot Marie-Christine, Guillaumont Sophie, QUALIREHAB Study Group
Аннотация
METHODS: The QUALIREHAB multicentre, randomized, controlled trial evaluated and implemented a 12-week centre- and home-based hybrid cardiac rehabilitation programme, including multidisciplinary care and physical activity sessions. Adolescent and young adult CHD patients with impaired cardiopulmonary fitness were randomly assigned to either the intervention (i.e. cardiac rehabilitation) or the standard of care. The primary outcome was the change in HRQoL from baseline to 12-month follow-up in an intention-to-treat analysis. The secondary outcomes were the change in cardiovascular parameters, cardiopulmonary fitness, and mental health.
RESULTS: The expected number of 142 patients was enroled in the study (mean age 17.4 ± 3.4 years, 52% female). Patients assigned to the intervention had a significant positive change in HRQoL total score [mean difference 3.8; 95% confidence interval (CI) 0.2; 7.3; P = .038; effect size 0.34], body mass index [mean difference -0.7 kg/m2 (95% CI -1.3; -0.1); P = .022; effect size 0.41], level of physical activity [mean difference 2.5 (95% CI 0.1; 5); P = .044; effect size 0.39], and disease knowledge [mean difference 2.7 (95% CI 0.8; 4.6); P = .007; effect size 0.51]. The per-protocol analysis confirmed these results with a higher magnitude of differences. Acceptability, safety, and short-time effect of the intervention were good to excellent.
CONCLUSIONS: This early hybrid cardiac rehabilitation programme improved HRQoL, body mass index, physical activity, and disease knowledge, in youth with CHD, opening up the possibility for the QUALIREHAB programme to be rolled out to the adult population of CHD and non-congenital cardiac disease.